Malin Corporation | MLC - Current Liabilities

Stock Price
7.95
Daily Change
0 0%
Monthly
3.25%
Yearly
-6.47%
Q2 Forecast
7.76

Malin Corporation reported EUR1000K in Current Liabilities for its fiscal semester ending in December of 2024.





Current Liabilities Change Date
Akebia Therapeutics USD 162.94M 29.56M Dec/2025
Alaunos Therapeutics USD 921K 153K Sep/2025
ALKERMES USD 543.44M 69.08M Dec/2025
Avita Medical AUD 62.68M 77K Dec/2025
Dianthus Therapeutics USD 30.73M 6.88M Dec/2025
Eurofins Scientific SE EUR 2.43B 344.6M Dec/2025
Ionis Pharmaceuticals USD 783M 120.46M Dec/2025
IQVIA Holdings USD 8.34B 170M Dec/2025
Lonza CHF 3.57B 421M Dec/2025
Malin Corporation EUR 1000K 500K Dec/2024
Moderna USD 1.99B 306M Dec/2025
Organon & Co USD 2.68B 117M Sep/2025
Ovoca Bio EUR 186K 2.26M Jun/2025
Revvity USD 1.33B 108.5M Dec/2025
Tectonic Therapeutic USD 9.67M 293K Dec/2025
Viatris USD 7.09B 269.8M Dec/2025
Xeris Pharmaceuticals USD 109.57M 6.63M Dec/2025